BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32382837)

  • 1. Signification of Systemic Immune-Inflammation Index for prediction of prognosis after resecting in patients with colorectal cancer.
    Yatabe S; Eto K; Haruki K; Shiba H; Kosuge M; Ohkuma M; Ito D; Takeda Y; Sugano H; Sasaki S; Yanaga K
    Int J Colorectal Dis; 2020 Aug; 35(8):1549-1555. PubMed ID: 32382837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic immune-inflammation index for predicting prognosis of colorectal cancer.
    Chen JH; Zhai ET; Yuan YJ; Wu KM; Xu JB; Peng JJ; Chen CQ; He YL; Cai SR
    World J Gastroenterol; 2017 Sep; 23(34):6261-6272. PubMed ID: 28974892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic Immune-Inflammation Index Predicts Tumor Recurrence after Radical Resection for Colorectal Cancer.
    Nakamoto S; Ohtani Y; Sakamoto I; Hosoda A; Ihara A; Naitoh T
    Tohoku J Exp Med; 2023 Nov; 261(3):229-238. PubMed ID: 37673651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma.
    Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z
    J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic value of combined tumor markers and systemic immune-inflammation index in colorectal cancer patients.
    Xie H; Yuan G; Huang S; Kuang J; Yan L; Ruan G; Tang S; Gan J
    Langenbecks Arch Surg; 2020 Dec; 405(8):1119-1130. PubMed ID: 32794068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The systemic immune-inflammation index is an independent predictor of survival for metastatic colorectal cancer and its association with the lymphocytic response to the tumor.
    Xie QK; Chen P; Hu WM; Sun P; He WZ; Jiang C; Kong PF; Liu SS; Chen HT; Yang YZ; Wang D; Yang L; Xia LP
    J Transl Med; 2018 Oct; 16(1):273. PubMed ID: 30286769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammation index, neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio can predict clinical outcomes in patients with metastatic non-small-cell lung cancer treated with nivolumab.
    Liu J; Li S; Zhang S; Liu Y; Ma L; Zhu J; Xin Y; Wang Y; Yang C; Cheng Y
    J Clin Lab Anal; 2019 Oct; 33(8):e22964. PubMed ID: 31282096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Immune-Inflammation Index (SII) is Useful to Predict Survival Outcomes in Patients After Liver Transplantation for Hepatocellular Carcinoma within Hangzhou Criteria.
    Fu H; Zheng J; Cai J; Zeng K; Yao J; Chen L; Li H; Zhang J; Zhang Y; Zhao H; Yang Y
    Cell Physiol Biochem; 2018; 47(1):293-301. PubMed ID: 29768257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A decreased preoperative platelet-to-lymphocyte ratio, systemic immune-inflammation index, and pan-immune-inflammation value are associated with the poorer survival of patients with a stent inserted as a bridge to curative surgery for obstructive colorectal cancer.
    Sato R; Oikawa M; Kakita T; Okada T; Abe T; Tsuchiya H; Akazawa N; Ohira T; Harada Y; Okano H; Ito K; Tsuchiya T
    Surg Today; 2023 Apr; 53(4):409-419. PubMed ID: 35987967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative systemic immune-inflammation index predicts prognosis and guides clinical treatment in patients with non-small cell lung cancer.
    Yan X; Li G
    Biosci Rep; 2020 Mar; 40(3):. PubMed ID: 32175568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Immune-inflammation Index Predicts Survival of Patients After Curative Resection for Non-small Cell Lung Cancer.
    Tomita M; Ayabe T; Maeda R; Nakamura K
    In Vivo; 2018; 32(3):663-667. PubMed ID: 29695576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-treatment systemic immune-inflammation index is a useful prognostic indicator in patients with breast cancer undergoing neoadjuvant chemotherapy.
    Chen L; Kong X; Wang Z; Wang X; Fang Y; Wang J
    J Cell Mol Med; 2020 Mar; 24(5):2993-3021. PubMed ID: 31989747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected non-small cell lung cancer.
    Guo W; Cai S; Zhang F; Shao F; Zhang G; Zhou Y; Zhao L; Tan F; Gao S; He J
    Thorac Cancer; 2019 Apr; 10(4):761-768. PubMed ID: 30734516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of systemic immune-inflammation index in patients with gastric cancer.
    Wang K; Diao F; Ye Z; Zhang X; Zhai E; Ren H; Li T; Wu H; He Y; Cai S; Chen J
    Chin J Cancer; 2017 Sep; 36(1):75. PubMed ID: 28899420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection.
    Jomrich G; Gruber ES; Winkler D; Hollenstein M; Gnant M; Sahora K; Schindl M
    J Gastrointest Surg; 2020 Mar; 24(3):610-618. PubMed ID: 30923999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic Immune-inflammation Index is the Best Prognostic Factor in Patients with Advanced Stage Adenocarcinoma of the Lung Treated with Pemetrexed.
    Bilgetekin I; Basal FB
    J Coll Physicians Surg Pak; 2020 Sep; 30(9):933-939. PubMed ID: 33036677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic immune-inflammation index predicts prognosis of patients with advanced pancreatic cancer.
    Zhang K; Hua YQ; Wang D; Chen LY; Wu CJ; Chen Z; Liu LM; Chen H
    J Transl Med; 2019 Jan; 17(1):30. PubMed ID: 30658662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.